McKeigue, Paul M.
Burgul, Raj
Bishop, Jen
Robertson, Chris
McMenamin, Jim
O’Leary, Maureen
McAllister, David A.
Colhoun, Helen M. http://orcid.org/0000-0002-8345-3288
Article History
Received: 21 September 2021
Accepted: 7 December 2021
First Online: 20 December 2021
Declarations
:
: This study was performed within Public Health Scotland as part of its statutory duty to monitor and investigate public health problems. Under the ExternalRef removed set out by the NHS Health Research Authority, this does not fall within the definition of research and ethical review is not required. Individual consent is not required for Public Health Scotland staff to process personal data to perform specific tasks in the public interest that fall within its statutory role. The statutory basis for this is set out in Public Health Scotland’s ExternalRef removed. A Data Protection Impact Assessment (DPIA) allows Public Health Scotland staff to link existing datasets. This study was approved under COVID-19 Rapid DPIA 20210023.
: HC receives research support and honoraria and is a member of advisory panels or speaker bureaus for Sanofi Aventis, Regeneron, Novartis, Novo-Nordisk and Eli Lilly. HC receives or has recently received non-binding research support from AstraZeneca and Novo-Nordisk. The other authors declare no competing interests.